International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Oncol Rep 32: [Related article:] 2267-2273, 2014; DOI: 10.3892/or.2014.3410
It has been brought to our attention that there was an important omission of the word ‘shRNA’, which should have been featured in a couple of places in the above article. The authors incorrectly claimed that the RNA-dependent protein kinase (PKR) acts as a tumor suppressor; in fact, it is the PKR shRNA that would fulfil the role of being a tumor suppressor. Therefore, the text in the Abstract on p. 2267, line 14, should have read ‘…these findings suggested that PKR shRNA acts as a tumor suppressor’; likewise, on p. 2272, towards the end of the final sentence of the second paragraph of the Discussion, the text should have read ‘The results show that PKR silencing inhibits tumor growth, suggesting that PKR shRNA acts as a tumor supressor…’.
The authors regret that this error was not corrected before the article went to print, and they thank the reader concerned for drawing the matter to our attention.